Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC388963 Inhibitors

Chemical inhibitors of LOC388963 operate through distinct mechanisms to inhibit the protein's function by targeting different components of the signaling pathways LOC388963 is involved in. Cyclopamine and Jervine perform their inhibitory roles by binding to the Smoothened receptor, a crucial component of the Hedgehog signaling pathway. When these molecules bind to the Smoothened receptor, they prevent its activation, which is necessary for the transmission of the Hedgehog signal. Vismodegib, PF-5274857, and MK-4101 also target the Smoothened receptor, though potentially through different binding sites or conformations. Their interaction with this receptor impedes the pathway's ability to propagate its signal, thereby inhibiting the functional activity of LOC388963. GANT61, on the other hand, acts downstream in the Hedgehog pathway. It targets the GLI transcription factors, which are vital for the expression of Hedgehog target genes. By inhibiting GLI, GANT61 can suppress the expression of downstream genes regulated by the Hedgehog pathway, thus affecting the functional output of LOC388963.

In the context of the Wnt signaling pathway, inhibitors such as TWS119, XAV939, IWP-2, LGK974, Salinomycin, and FH535 operate by disrupting various components of the pathway. TWS119 inhibits GSK-3β, a kinase that plays a critical role in the Wnt pathway by regulating β-catenin stability, and by this action, it can alter the activity of LOC388963 if LOC388963 is associated with Wnt-mediated processes. XAV939 works by stabilizing axin proteins through inhibition of tankyrase, leading to the downregulation of the Wnt/β-catenin signaling cascade. IWP-2 prevents the secretion of Wnt proteins, which are necessary for activating Wnt signaling, and thus, can influence LOC388963 activity indirectly. LGK974 targets the Porcupine enzyme, essential for the post-translational modification of Wnt proteins, and its inhibition can affect the maturation and signaling capability of Wnt proteins. Salinomycin interferes with the interaction between Wnt proteins and their receptor LRP6, disrupting the signaling process. Lastly, FH535 inhibits the Wnt/β-catenin pathway, and by doing so, can modulate the functional activity of LOC388963 if it is linked to this signaling route. Each of these inhibitors acts at distinct points in the signaling pathways, thereby exerting their influence on LOC388963 through the modulation of pathway-specific components and processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$94.00
$208.00
19
(1)

Cyclopamine specifically inhibits the Hedgehog signaling pathway by binding to and inhibiting the Smoothened receptor, which is crucial for signal transduction. Blocking this receptor can inhibit LOC388963 if the protein is involved in the Hedgehog pathway.

Vismodegib

879085-55-9sc-396759
sc-396759A
10 mg
25 mg
$82.00
$158.00
1
(0)

Vismodegib is designed to inhibit the Hedgehog signaling pathway by directly interacting with the Smoothened receptor. This interaction prevents the activation of the pathway, thus functionally inhibiting LOC388963 if the protein is part of the Hedgehog pathway's regulatory network.

GANT61

500579-04-4sc-202630
sc-202630A
sc-202630B
1 mg
5 mg
10 mg
$64.00
$131.00
$204.00
6
(1)

GANT61 acts by targeting GLI transcription factors within the Hedgehog signaling pathway, inhibiting their function. If LOC388963's activity is linked to the downstream effects of GLI, then GANT61 can inhibit LOC388963 by disrupting these downstream signals.

Jervine

469-59-0sc-200934
sc-200934A
1 mg
5 mg
$66.00
$240.00
1
(0)

Jervine is a Hedgehog pathway inhibitor that, like Cyclopamine, binds to and inhibits the Smoothened receptor. This inhibition can functionally inhibit LOC388963 if it operates within or downstream of the Hedgehog signaling pathway.

PF-5274857

1373615-35-0sc-478208
5 mg
$360.00
(0)

PF-5274857 specifically inhibits the Hedgehog pathway by binding to the Smoothened receptor. Inhibition of this receptor will reduce the functional activity of LOC388963 if the protein's function is regulated by Hedgehog signaling.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$36.00
$117.00
$525.00
26
(1)

XAV939 functions as an inhibitor of the Wnt pathway by stabilizing axin proteins through tankyrase inhibition. This stabilization inhibits the Wnt/β-catenin signaling cascade, thereby functionally inhibiting LOC388963 if it is a part of Wnt signaling.

IWP-2

686770-61-6sc-252928
sc-252928A
5 mg
25 mg
$96.00
$292.00
27
(1)

IWP-2 inhibits the Wnt signaling pathway by preventing the secretion of Wnt proteins. Inhibition of Wnt ligand secretion would functionally inhibit LOC388963 if the protein's activity is mediated through the Wnt pathway.

LGK 974

1243244-14-5sc-489380
sc-489380A
5 mg
50 mg
$359.00
$1295.00
2
(0)

LGK974 inhibits the Wnt signaling pathway by targeting the Porcupine enzyme, which is involved in the post-translational modification of Wnt proteins. This inhibition can functionally inhibit LOC388963 by blocking Wnt protein maturation and signaling.

Salinomycin

53003-10-4sc-253530
sc-253530C
sc-253530A
sc-253530B
5 mg
10 mg
25 mg
100 mg
$162.00
$241.00
$406.00
$474.00
1
(1)

Salinomycin is known to disrupt Wnt signaling by interfering with the Wnt/LRP6 interaction. This disruption can lead to a functional inhibition of LOC388963 by blocking the signaling that would normally be mediated through the Wnt/LRP6 complex.

β-Catenin/Tcf Inhibitor, FH535

108409-83-2sc-221398
sc-221398A
10 mg
50 mg
$182.00
$374.00
7
(1)

FH535 works by inhibiting the Wnt/β-catenin pathway. It is known to inhibit both Wnt signaling and peroxisome proliferator-activated receptor (PPAR) signaling. This dual inhibition can functionally inhibit LOC388963 by disrupting the Wnt/β-catenin pathway, assuming LOC388963's activity is affected by Wnt signaling.